Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

3

US Approved Rx

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

3

1955

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Acute renal failure

1

Asthma

1

Cerebral edema

1

Constipation

1

Cystic fibrosis

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Diagnostic

1

Palliative

1

Preventing

1

Primary

1

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Non-penetrant

1

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Proust, J.L.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Concept

3

Chemical

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

4

NDF-RT

4

WHO-ATC

4

EVMPD

2

CHEBI

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ALIMENTARY TRACT AND METABOLISM

4

BLOOD AND BLOOD FORMING ORGANS

4

RESPIRATORY SYSTEM

4

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS

4

COUGH AND COLD PREPARATIONS

4

LAXATIVES

4

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS

4

I.V. SOLUTIONS

4

IRRIGATING SOLUTIONS

4

LAXATIVES

4

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Mucolytics

4

Osmotically acting laxatives

4

Other irrigating solutions

4

Solutions producing osmotic diuresis

4

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Established Pharmacologic Class [EPC]|Osmotic Diuretic [EPC]" in comments (approximate match)

Showing 1 - 4 of 4 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

MANNITOL

3OWL53L36A

Export Data
Search for Structure

Status:

US Approved Rx (2020)

First approved in 1955

Class (Stereo):

CHEMICAL (ABSOLUTE)

Conditions:

End-Stage Renal Disease

Cystic fibrosis

Acute renal failure

Elevated intraocular pressure

Mannitol is an osmotic diuretic that is metabolically inert in humans and occurs naturally, as a sugar or sugar alcohol, in fruits and vegetables. Mannitol elevates blood plasma osmolality, resulting in enhanced flow of water from tissues, including ...

the brain and cerebrospinal fluid, into interstitial fluid and plasma. As a result, cerebral edema, elevated intracranial pressure, and cerebrospinal fluid volume and pressure may be reduced. Mannitol (marketed under the brand Osmitrol) may also be used for the promotion of diuresis before irreversible renal failure becomes established; the promotion of urinary excretion of toxic substances; as an Antiglaucoma agent; and as a renal function diagnostic aid. Mannitol, the active ingredient in ARIDOL, is indicated for the assessment of bronchial hyperresponsiveness in patients 6 years of age or older who do not have clinically apparent asthma. Mannitol is an osmotic diuretic that is metabolically inert in humans and occurs naturally, as a sugar or sugar alcohol, in fruits and vegetables. Mannitol elevates blood plasma osmolality, resulting in enhanced flow of water from tissues, including the brain and cerebrospinal fluid, into interstitial fluid and plasma. As a result, cerebral edema, elevated intracranial pressure, and cerebrospinal fluid volume and pressure may be reduced. As a diurectic mannitol induces diuresis because it is not reabsorbed in the renal tubule, thereby increasing the osmolality of the glomerular filtrate, facilitating excretion of water, and inhibiting the renal tubular reabsorption of sodium, chloride, and other solutes. Mannitol promotes the urinary excretion of toxic materials and protects against nephrotoxicity by preventing the concentration of toxic substances in the tubular fluid. As an Antiglaucoma agent mannitol elevates blood plasma osmolarity, resulting in enhanced flow of water from the eye into plasma and a consequent reduction in intraocular pressure. As a renal function diagnostic aid mannitol is freely filtered by the glomeruli with less than 10% tubular reabsorption. Therefore, its urinary excretion rate may serve as a measurement of glomerular filtration rate (GFR).

MANNITOL 2080

3OWL53L36A

Status:

Other

Class:

CONCEPT

MANNITOL 300

3OWL53L36A

Status:

Other

Class:

CONCEPT

MANNITOL 60

3OWL53L36A

Status:

Other

Class:

CONCEPT

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1